Titanium Oxide Nanotube Column for Antibiotic Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for removing antibiotics from dairy products, such as milk, are inefficient and environmentally insensitive, and existing titanium oxide nanostructures have not been effectively utilized for this purpose, particularly for β-lactam antibiotics.
Innovation Solution
The use of titanium oxide nanostructures with a formula HxNa2-xTi2O5.(H2O), where x≤2, in the form of nanotubes with an average diameter of 5 to 200 nm, as a stationary phase in a column to selectively remove antibiotics from dairy products, with a bulk composition of at least 75% titanium oxide and minimal additional materials, under controlled pH and pressure conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods (liquid-liquid extraction, UV irradiation) are used to remove antibiotics from dairy products, then antibiotic removal efficiency is improved, but environmental sensitivity deteriorates and contamination problems arise
Solution Approach 1:
The patent employs TiO2 nanotubes with controlled porosity and high surface area to volume ratio as the stationary phase. The nanotube structure provides numerous active sites for antibiotic adsorption while maintaining environmental benignity. The porous structure allows selective penetration of antibiotic molecules while excluding larger dairy components, achieving efficient removal without harmful solvents or irradiation.
Solution Approach 2:
The patent uses composite stationary phases combining TiO2 nanotubes with other materials (such as silica, polymers, or metal oxides) to enhance both antibiotic removal efficiency and environmental compatibility. The composite structure synergistically combines the high surface area of nanotubes with the selective properties of partner materials, improving productivity while maintaining environmental sensitivity.
2Manufacturing precision
If titanium oxide nanostructures are used as stationary phase with high titanium oxide content (at least 75 wt.%), then selectivity for antibiotic removal is improved, but manufacturing complexity increases
Solution Approach 1:
The patent optimizes critical parameters including TiO2 nanotube diameter (5-200 nm), length, crystalline phase composition (anatase, rutile, brookite ratios), and surface area to volume ratio. By precisely controlling these parameters during synthesis, the patent achieves high antibiotic selectivity while managing manufacturing complexity through standardized synthesis protocols and parameter ranges.
Solution Approach 2:
The patent segments the stationary phase into discrete TiO2 nanotube structures with controlled dimensions and pore sizes. This segmentation creates uniform active sites throughout the stationary phase, ensuring consistent selective adsorption behavior. The segmented nanotube architecture also simplifies manufacturing by enabling batch synthesis and standardized packing procedures.
3Area of moving object
If nanotubes with small diameter (5-200 nm) are used, then surface area for adsorption is improved, but difficulty of detecting and measuring increases
Solution Approach 1:
The patent employs indirect detection methods that monitor bulk properties (such as UV-Vis absorption changes, fluorescence quenching, or HPLC elution profiles) rather than directly imaging or characterizing individual nanotubes. This copying approach translates nanoscale adsorption events into macroscopic measurable signals, maintaining high surface area benefits while eliminating detection difficulties.
Solution Approach 2:
The patent uses intermediary detection techniques where the adsorption of antibiotics onto TiO2 nanotubes is detected through secondary effects such as changes in UV-Vis absorption spectra, fluorescence intensity, or chromatographic retention times. These intermediary measurements provide indirect but reliable detection of antibiotic removal without requiring direct observation of the nanoscale nanotube structures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces antibiotic concentrations in dairy products by up to 85% while minimizing the removal of non-antibiotic components, achieving high selectivity and efficiency in separating antibiotics from milk, particularly β-lactam antibiotics, with the ability to handle high initial antibiotic concentrations and maintain separation efficiency across multiple cycles.
Implementation Method 1
TiO2 nanomaterials with controlled morphology, such as nanotubes, nanowires, nanorods, nanospheres, etc., have been used in various processes because of their inertness and low cost. Previous efforts have shown TiO2 to be an excellent adsorbent for polycyclic aromatic hydrocarbons (PAHs)
Data Source
AI summary
A method of removing one or more antibiotics from a dairy product, the method involve passing the dairy product comprising an antibiotic in a first amount through a bulk comprising, relative to a total bulk weight, at least 75 wt. % of titanium oxide nanostructures, to provide the dairy product comprising the antibiotic in a second, lesser amount, wherein the nanostructures have lengths at least two-fold in excess of their width and height. Bulk materials useful in this or related methods or applications may have loosely tangled, noodle-like morphologies on sub-100 nm scale, and need not employ graphene and/or polymeric support networks in columns, generally having only titanium oxides without silicon or iron oxides.